15 news items
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUL
6 May 24
(cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
OCUL
6 May 24
(cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short-term
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
OCUL
3 May 24
clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
OCUL
1 May 24
with allergic conjunctivitis. ELUTYX is also the foundation for two other clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
OCUL
18 Apr 24
the foundation for two other clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED
9h1ma3
OCUL
16 Apr 24
) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry
limyvzwv0mwgbo6d2qdp 3bkr4c
OCUL
15 Apr 24
conjunctivitis. ELUTYX is also the foundation for two other clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment
y11rdr0xmsjt1w6kslwre0cuavxxfdsv485iskqiuo09
OCUL
9 Apr 24
(cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short-term
5urqf96gypfpqcw6dshrxzqu25
OCUL
6 Apr 24
the risk of stacking, critical for the treatment of chronic disease. The totality of these features makes me optimistic about this product candidate
72yirmx5s16nk0hunudoujikuhvuak6qbtvzagoktjdepfkhwicpxrv
OCUL
26 Mar 24
other clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease
ih4pxt74q
ACAD
CLRO
CTMX
12 Mar 24
recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.
ATRenew Inc
vxjzr439dmu8d1pdsll7tt1h1ecc l4dxwj6k8hr0gwddu27tc
OCUL
5 Mar 24
assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED
hayv7v5i6e 2cu6bqcuy7u1
OCUL
22 Feb 24
other clinical-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease
iezk1rh0gom0zf60h
OCUL
22 Feb 24
for the treatment of primary open-angle glaucoma or ocular hypertension; and OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry
ak4slpfix251du6066h75b855f7inrkfu27g0aa4wjbn
OCUL
22 Feb 24
-stage assets, OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED
- Prev
- 1
- Next